When was Sama Therapeutics founded?

Sama Therapeutics was founded in 2022.

Where is Sama Therapeutics located?

Sama Therapeutics is headquartered in Cambridge, United States.

Who is the current CEO of Sama Therapeutics?

Shobi Ahmed of Sama Therapeutics. They have also founded 1 company.

How many employees does Sama Therapeutics have?

As of Apr 30, 2026, the latest employee count at Sama Therapeutics is 19.

Is Sama Therapeutics a funded company?

Sama Therapeutics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Sama Therapeutics rank among its competitors?

Sama Therapeutics ranks 55th amongst 150 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BrainCheck, which secured $500K in Dec, 2025.

Who are the top competitors of Sama Therapeutics?

Sama Therapeutics' top competitors include BrainCheck, Altoida and Cambridge Cognition. Among them, BrainCheck secured the most recent funding round in December, 2025.

Sama Therapeutics - 2026 Company Profile, Team & Competitors

Sama Therapeutics is an unfunded company based in Cambridge (United States), founded in 2022 by Adam Teed, Aurina Arnatkeviciute, Shobi Ahmed and Elias Mouchlianitis. It operates as a Developer of an AI platform for precision neuropsychiatry and brain health. Sama Therapeutics has not raised any funding yet. The company has 150 active competitors, including 27 funded and 11 that have exited. Its top competitors include companies like BrainCheck, Altoida and Cambridge Cognition.

Company Details

Developer of an AI platform for precision neuropsychiatry and brain health. The company offers a software as medical device platform for cognitive, affective, interoceptive, and substance use disorders. The platform analyzes the efficacy of pharmaceutical and neurostimulation modalities through clinical trials, deep phenotyping, causal inference, digital twins, and preclinical translation. The technology generates reports and insights for healthcare providers and individuals.

Website: sama.ac
Social
Email ID: *****@sama.ac

Key Metrics

Founded Year

2022

Location

Cambridge, United States

Stage

Unfunded

Ranked

55^th among 150 active competitors

Employee Count

19 as on Apr 30, 2026

Similar Companies

Innovaccer & 2466 more

View Sama Therapeutics' full profile

Sama Therapeutics has not raised any funding rounds yet.

The founders of Sama Therapeutics are Adam Teed, Aurina Arnatkeviciute, Shobi Ahmed and Elias Mouchlianitis. Shobi Ahmed is the CEO of Sama Therapeutics.

Here are the details of Sama Therapeutics' key team members:

Adam Teed: Co-Founder of Sama Therapeutics.
Contact Info: 1 email address
Aurina Arnatkeviciute: Co-Founder of Sama Therapeutics.
Shobi Ahmed: Co-Founder & CEO of Sama Therapeutics.
Contact Info: 1 email address
Elias Mouchlianitis: Co-Founder of Sama Therapeutics.
Contact Info: 1 email address

View details of Sama Therapeutics's Founder profiles and Board Members

Sama Therapeutics' employee count trend

Sama Therapeutics has 19 employees as of Apr 26. Here is Sama Therapeutics's employee count trend over the years:

Employee count trend for Sama Therapeutics

Uncover Sama Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sama Therapeutics include BrainCheck, Altoida and Cambridge Cognition. Here is the list of Top 10 competitors of Sama Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BrainCheck 2014, Houston (United States), Series C	Mobile games for cognitive health tracking	$36.8M	S3 Ventures, Next Coast Ventures & 17 others	62/100
2nd	Altoida 2016, Lucerne (Switzerland), Series A	Provider of a AI-based app which can predict the onset of Alzheimer's	$21.5M	M Ventures, Polytech Ventures & 12 others	55/100
3rd	Cambridge Cognition 2002, Cambridge (United Kingdom), Public	Computerized neuropsychological tests for cognitive assessment	-	First Star Ventures, Psion Partners	52/100
4th	Strados Labs 2016, Philadelphia (United States), Series A	Provider of a wearable device for breathing monitoring	$6.36M	Ben Franklin Technology Partners, HAX & 11 others	52/100
5th	Linus Health 2019, Boston (United States), Series B	Provider of digital cognitive assessment platform and brain health management tools	$64.9M	Morningside, HHS	51/100
6th	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$24.4M	SBI Investment Korea, ES Investor & 14 others	50/100
7th	Thymia 2020, Hereford (United Kingdom), Seed	AI-based video games for patient's psychological and mental health assessment	$3.8M	Kodori, Calm/Storm & 12 others	48/100
8th	Winterlight Labs 2015, Toronto (Canada), Acquired	AI-powered speech analysis technology to detect cognitive impairments	$5.73M	Hikma Ventures, Grey Sky Venture Partners ... & 8 others	47/100
9th	Cognetivity 2013, London (United Kingdom), Public	AI based platform offering brain health diagnosis tool for providers	-	Gov.uk, Intrynsyc Capital	46/100
10th	Jvion 2011, Suwanee (United States), Acquired	Provider of a deep learning-based solution for predicting illness	$11.1M	JMI Management, Trinity Health & 7 others	46/100
55th	Sama Therapeutics 2022, Cambridge (United States), Unfunded	Developer of an AI platform for precision neuropsychiatry and brain health	-	-	31/100